ACADIA Pharmaceuticals, Inc. (ACAD)
29.16
-0.57
(-1.92%)
USD |
NASDAQ |
Aug 28, 13:05
ACADIA Pharmaceuticals Total Return Price : 29.16 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 27, 2026 | 29.73 |
| August 26, 2026 | 29.58 |
| August 25, 2026 | 30.57 |
| August 24, 2026 | 29.65 |
| August 21, 2026 | 29.50 |
| August 20, 2026 | 29.04 |
| August 19, 2026 | 30.21 |
| August 18, 2026 | 30.18 |
| August 17, 2026 | 29.01 |
| August 14, 2026 | 28.24 |
| August 13, 2026 | 28.38 |
| August 12, 2026 | 29.45 |
| August 11, 2026 | 29.41 |
| August 10, 2026 | 29.39 |
| August 07, 2026 | 29.21 |
| August 06, 2026 | 28.45 |
| August 05, 2026 | 28.80 |
| August 04, 2026 | 27.15 |
| August 03, 2026 | 25.61 |
| July 31, 2026 | 25.87 |
| July 30, 2026 | 26.55 |
| July 29, 2026 | 26.34 |
| July 28, 2026 | 26.01 |
| July 27, 2026 | 25.39 |
| July 24, 2026 | 24.84 |
| Date | Value |
|---|---|
| July 23, 2026 | 24.83 |
| July 22, 2026 | 24.96 |
| July 21, 2026 | 25.43 |
| July 20, 2026 | 25.09 |
| July 17, 2026 | 25.60 |
| July 16, 2026 | 25.63 |
| July 15, 2026 | 25.92 |
| July 14, 2026 | 25.49 |
| July 13, 2026 | 25.50 |
| July 10, 2026 | 26.22 |
| July 09, 2026 | 26.41 |
| July 08, 2026 | 26.00 |
| July 07, 2026 | 26.20 |
| July 06, 2026 | 25.77 |
| July 02, 2026 | 25.97 |
| July 01, 2026 | 25.20 |
| June 30, 2026 | 25.30 |
| June 29, 2026 | 25.20 |
| June 26, 2026 | 25.32 |
| June 25, 2026 | 23.72 |
| June 24, 2026 | 23.36 |
| June 23, 2026 | 22.60 |
| June 22, 2026 | 22.09 |
| June 18, 2026 | 21.62 |
| June 17, 2026 | 21.60 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Incyte Corp. | 124.92 |
| Agios Pharmaceuticals, Inc. | 33.49 |
| Biogen, Inc. | 217.19 |
| Insmed, Inc. | 118.36 |
| Vertex Pharmaceuticals, Inc. | 542.56 |